DRD2 and prolactin-producing pituitary gland adenoma: This two-center retrospective cohort study investigated the expression patterns of dopamine 2 (D2R), SST2 and SST5 receptors in surgical specimen of 34 patients with prolactinomas, 22 of which were DA-resistant.